BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 28721860)

  • 1. One year in review 2017: systemic lupus erythematosus.
    La Paglia GMC; Leone MC; Lepri G; Vagelli R; Valentini E; Alunno A; Tani C
    Clin Exp Rheumatol; 2017; 35(4):551-561. PubMed ID: 28721860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic lupus erythematosus in children and adolescents].
    Sallmann S; Fiebig B; Hedrich CM; Heubner G; Gahr M
    Z Rheumatol; 2006 Nov; 65(7):576-8, 580-2, 584-5. PubMed ID: 17072573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One year in review 2018: systemic lupus erythematosus.
    Di Battista M; Marcucci E; Elefante E; Tripoli A; Governato G; Zucchi D; Tani C; Alunno A
    Clin Exp Rheumatol; 2018; 36(5):763-777. PubMed ID: 30272543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.
    AlFadhli S; AlFailakawi A; Ghanem AA
    Int J Rheum Dis; 2016 May; 19(5):512-20. PubMed ID: 25496163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.
    Mohan C; Putterman C
    Nat Rev Nephrol; 2015 Jun; 11(6):329-41. PubMed ID: 25825084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One year in review 2015: systemic lupus erythematosus.
    Mirabelli G; Cannarile F; Bruni C; Vagelli R; De Luca R; Carli L
    Clin Exp Rheumatol; 2015; 33(3):414-25. PubMed ID: 26106941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent investigations on the basis of pathogenesis of SLE and new therapeutic approaches].
    Watanabe N; Takabayashi K
    Nihon Rinsho; 2009 Mar; 67(3):500-5. PubMed ID: 19280923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE.
    das Chagas Medeiros MM; Bezerra MC; Braga FN; da Justa Feijão MR; Gois AC; Rebouças VC; de Carvalho TM; Carvalho LN; Ribeiro ÁM
    Lupus; 2016 Apr; 25(4):355-63. PubMed ID: 26405022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine and Human Lupus Nephritis: Pathogenic Mechanisms and Theoretical Strategies for Therapy.
    Pedersen HL; Horvei KD; Thiyagarajan D; Seredkina N; Rekvig OP
    Semin Nephrol; 2015 Sep; 35(5):427-38. PubMed ID: 26573545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype.
    Ceccarelli F; Perricone C; Borgiani P; Ciccacci C; Rufini S; Cipriano E; Alessandri C; Spinelli FR; Sili Scavalli A; Novelli G; Valesini G; Conti F
    J Immunol Res; 2015; 2015():745647. PubMed ID: 26798662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
    Verma J; Arora V; Marwaha V; Kumar A; Das N
    Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus.
    D'Cruz DP; Khamashta MA; Hughes GR
    Lancet; 2007 Feb; 369(9561):587-96. PubMed ID: 17307106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus: still a challenge for physicians.
    Bengtsson AA; Rönnblom L
    J Intern Med; 2017 Jan; 281(1):52-64. PubMed ID: 27307107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab].
    Tsanyan ME; Torgashina AV; Aleksandrova EN; Soloviev SK; Nasonov EL
    Ter Arkh; 2013; 85(5):53-9. PubMed ID: 23819340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis.
    Niu Z; Zhang P; Tong Y
    Int J Rheum Dis; 2015 Jan; 18(1):17-28. PubMed ID: 25546242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging therapies in systemic lupus erythematous: from clinical trial to the real life.
    Zhang H; Chambers W; Sciascia S; Cuadrado MJ
    Expert Rev Clin Pharmacol; 2016; 9(5):681-94. PubMed ID: 26907827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus and lupus nephritis.
    Koutsokeras T; Healy T
    Nat Rev Drug Discov; 2014 Mar; 13(3):173-4. PubMed ID: 24525782
    [No Abstract]   [Full Text] [Related]  

  • 19. Revisiting the complement system in systemic lupus erythematosus.
    Sharma M; Vignesh P; Tiewsoh K; Rawat A
    Expert Rev Clin Immunol; 2020 Apr; 16(4):397-408. PubMed ID: 32228236
    [No Abstract]   [Full Text] [Related]  

  • 20. Childhood-onset systemic lupus erythematosus: an update.
    Borgia RE; Silverman ED
    Curr Opin Rheumatol; 2015 Sep; 27(5):483-92. PubMed ID: 26200474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.